Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Palazzo

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Biochemical Society Transactions|November 14, 2018
PARPs in genome stability and signal transduction: implications for cancer therapyLuca Palazzo, Ivan Ahel
Cells|January 14, 2021
Mono(ADP-ribosyl)ation Enzymes and NAD<sup>+</sup> Metabolism: A Focus on Diseases and Therapeutic PerspectivesPalmiro Poltronieri, Angela Celetti, Luca Palazzo
The FEBS Journal|April 7, 2017
ADP-ribosylation: new facets of an ancient modificationLuca Palazzo, Andreja Mikoč, Ivan Ahel
Cell Cycle (Georgetown, Tex.)|January 19, 2010
Requirement for proteolysis in spindle assembly checkpoint silencingRoberta Visconti, Luca Palazzo, Domenico Grieco
Pathogens (Basel, Switzerland)|February 25, 2023
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial StrategiesGiuliana Catara, Rocco Caggiano, Luca Palazzo
Current Opinion in Genetics & Development|August 2, 2021
Serine ADP-ribosylation in DNA-damage response regulationLuca Palazzo, Marcin J Suskiewicz, Ivan Ahel
Open Biology|April 18, 2019
ADP-ribosylation signalling and human diseaseLuca Palazzo, Petra Mikolčević, Andreja Mikoč, et al.
Biochemical Pharmacology|February 6, 2026
The PARG frontier: mechanisms of PAR turnover and opportunities in precision oncologyGiuliana Catara, Gaetano Gerace, Raffaella Lauro, et al.
DNA Repair|June 28, 2025
PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkersJoséphine Groslambert, Kira Schützenhofer, Luca Palazzo, et al.
Genes & Development|February 8, 2020
(ADP-ribosyl)hydrolases: structure, function, and biologyJohannes Gregor Matthias Rack, Luca Palazzo, Ivan Ahel
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Biochemical Society Transactions|November 14, 2018
PARPs in genome stability and signal transduction: implications for cancer therapyLuca Palazzo, Ivan Ahel
Cells|January 14, 2021
Mono(ADP-ribosyl)ation Enzymes and NAD<sup>+</sup> Metabolism: A Focus on Diseases and Therapeutic PerspectivesPalmiro Poltronieri, Angela Celetti, Luca Palazzo
The FEBS Journal|April 7, 2017
ADP-ribosylation: new facets of an ancient modificationLuca Palazzo, Andreja Mikoč, Ivan Ahel
Cell Cycle (Georgetown, Tex.)|January 19, 2010
Requirement for proteolysis in spindle assembly checkpoint silencingRoberta Visconti, Luca Palazzo, Domenico Grieco
Pathogens (Basel, Switzerland)|February 25, 2023
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial StrategiesGiuliana Catara, Rocco Caggiano, Luca Palazzo
Current Opinion in Genetics & Development|August 2, 2021
Serine ADP-ribosylation in DNA-damage response regulationLuca Palazzo, Marcin J Suskiewicz, Ivan Ahel
Open Biology|April 18, 2019
ADP-ribosylation signalling and human diseaseLuca Palazzo, Petra Mikolčević, Andreja Mikoč, et al.
Biochemical Pharmacology|February 6, 2026
The PARG frontier: mechanisms of PAR turnover and opportunities in precision oncologyGiuliana Catara, Gaetano Gerace, Raffaella Lauro, et al.
DNA Repair|June 28, 2025
PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkersJoséphine Groslambert, Kira Schützenhofer, Luca Palazzo, et al.
Genes & Development|February 8, 2020
(ADP-ribosyl)hydrolases: structure, function, and biologyJohannes Gregor Matthias Rack, Luca Palazzo, Ivan Ahel
Pageof 4